Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core

The discovery and SAR study of a novel 1,3,5-pyrazole series of human glucagon receptor antagonists represented by 26 are presented. Compound 26 was selective and orally active in several in vivo preclinical models of type II diabetes.